The 1st Major Advance in Spinal Fusion Bone Growth Stimulator Technology in Nearly 20 Years

Only the ActaStim® System combines clinically proven therapy,1,2 continuous wearability, and actionable, daily patient insights to better support a successful healing journey.
ActaStim S

AAOS INVESTOR DAY

Special presentation by our President & CEO Chris McAuliffe

Heading to the Bay for AAOS? Don’t miss this insightful look at how the ActaStim® System benefits patients and HCPs by supporting adherence and capturing metrics that help guide recovery.

  • Where: Canaccord Genuity 2024 Musculoskeletal Conference
  • When: Monday at 10:30 am, February 12, 2024

The ActaStim System

Intentionally designed to improve patient compliance and spinal fusion success

Continuous wearability supports all-day healing

As clinical and preclinical studies suggest, noninvasive electrical stimulation may be dose-dependent.3,4 ActaStim-S frees patients to go about their day as they benefit from continuous therapy.

Daily insights to help guide recovery

Clear charts and graphs combine auto-captured wear time & relative activity level data with self-reported pain scores. So it’s easy to see when patients get off track — and how to guide them back in the right direction.

Watch Video

The ActaStim difference

See what this innovative spinal fusion bone growth stimulator (BGS) system can do for you, your practice, and your patients.
HCP_VIDEO_THUMBNAIL

TESTIMONIALS

What surgeons & patients say

CONTINUOUS WEARABILITY

Fits into your patient’s pocket — and their life

As the most compact BGS,5 the discreet and portable ActaStim-S makes it easier for patients to follow their recovery regimen, including:
Wear time — Patients can simply tuck it into a pocket, clip it on their belt, or set it on a nearby surface.
Physical activity — Unlike bulky, older devices, ActaStim-S doesn’t restrict movement, limit postural positions, or require patients to schedule their lives around using it.

system COMPARISON

ActaStim vs. legacy spinal fusion bone growth stimulators

SAFE & EFFECTIVE

Double the chance for a successful outcome

ActaStim-S delivers a Level 1 evidence, clinically proven, FDA-approved therapeutic signal.1

31%

increase in fusion
success, regardless of
the type of fusion2

as likely to have a
successful outcome1

56%

reduction in
failure rates2

You treat patients — not x-rays

Older technologies were approved using only radiographic evidence.6,7 The signal delivered by ActaStim-S was approved using both radiographic and clinical evidence.1

Built on trusted technology

The signal delivered by ActaStim-S was proven safe & effective in a Level I clinical study and has been prescribed clinically for over 20 years.1

More potential healing benefits

Pre-clinical evidence demonstrates that the stimulation delivered by ActaStim-S produced ever-increasing bone cell proliferation throughout the day.3

DAILY INSIGHTS

A new window into patient progress

You can’t be with patients every moment of their healing journey — but ActaStim can. It’s the only system that:

  • Automatically collects accurate, continuous recovery metrics
  • Keeps patients engaged by letting them enter and manage data in the user-friendly ActaStim Sync app
  • Combines all that data into reports that show you at-a-glance whether patients are staying on track

True wear time

ActaStim-S tracks true device wear time, starting only when it’s applied to the patient’s skin.
Other devices record the amount of time they’re powered on, whether the patient is wearing them or not.

VIP CUSTOMER CARE

For your patients & your practice

We partner closely with healthcare providers and their patients for the entire healing journey:
  • We support your staff, keeping you in the loop while implementing your vision for each patient’s recovery.
  • A dedicated rep helps every patient set up their device, download and use the app, and get ongoing support.
  • Plus, we navigate the insurance claims process, optimizing coverage, and tailoring payment plans.

Resources

Product documents

Key resources for you & your patients.

Physician guide

Detailed guide to the device and how to use it.

Patient quick start guide

How to assemble, activate, and troubleshoot ActaStim-S.

Instructions for use

Detailed guide to the device and how to use it.

FAQs

What prescribers may want to know

Will I have access to the data my patients collect with the ActaStim Sync App?

Yes. Your local Theragen representative can provide you with reports, and patients may also present ActaStim Sync summary data directly from their phone during follow-up appointments.

How are my patients fitted with ActaStim-S, and how do they learn to use the digital app?

First, your dedicated Theragen representative will meet with patients to go over how to set up and use Actastim-S. At this same time, your representative will help them download the digital app, sync the app to the device, and review how to use the app on their phone to get them started.

When can patients start wearing the ActaStim-S device after lumbar spine fusion surgery?

At the surgeon’s discretion, most surgical approaches are compatible with starting a patient’s spine stimulator therapy anytime from immediately post-op to two weeks post-op. However, it is essential to note that electrodes should not be placed directly over unhealed incisions.

How much does ActaStim-S cost the patient?

The patient’s insurance plan dictates the patient’s financial responsibility. Our reimbursement experts will assist with all payor submissions, and if for some reason reimbursement is not available, we can customize a payment plan to make the device affordable. Theragen will explore numerous options to help patients receive the care they need.

REACH OUT

Questions? Suggestions? Need support?

Contact our Theragen team and an ActaStim-S Representative will be happy to assist you,
NOTE: Do not send Patient Health Information (PHI) through this form. If you have questions related to a specific patient, please select “patient question” as your inquiry type and a representative will contact you as soon as possible.

References:

1. U.S. Food and Drug Administration. (2020). PMA P190030: FDA Summary of Safety and Effectiveness Data.
2. Goodwin CB, Brighton CT, Guyer RD, Johnson JR, Light KI, Yuan HA. A double-blind study of capacitively coupled electrical stimulation as an adjunct to lumbar spinal fusions. Spine. 1999;24(13):1349-1356.
3. Brighton CT, Wang W, Seldes R, Zhang G, Pollack SR. Signal transduction in electrically stimulated bone cells. J Bone Joint Surg Am. 2001;83-A(10):1514-1523.
4. Mooney V. A randomized double-blind prospective study of the efficacy of pulsed electromagnetic fields for interbody lumbar fusions. Spine. (Phila Pa 1976). 1990 Jul;15(7):708-12. doi: 10.1097/00007632-199007000-00016. PMID: 2218718.
5. Data on File.
6.  American Medical Electronics. (1986). PMA P850007: Physio-Stim Summary of Safety and Effectiveness Data.
7.  OrthoLogic. (1999). PMA P910066: Spinalogic Bone Growth Stimulator Summary of Safety and Effectiveness.

REACH OUT

Questions? Suggestions? Need support?

Contact our Theragen team and an ActaStim-S Representative will be happy to assist you,
NOTE: Do not send Patient Health Information (PHI) through this form. If you have questions related to a specific patient, please select “patient question” as your inquiry type and a representative will contact you as soon as possible.

Contact us